T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease - Top-Institutions - MDSpire

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

  • By

  • Eduarda Leite-Gomes

  • Mariana C Silva

  • Ana M Dias

  • Ângela Fernandes

  • Guilherme Faria

  • Rafaela Nogueira

  • Beatriz Santos-Pereira

  • Henrique Fernandes-Mendes

  • Catarina M Azevedo

  • Joana Raposo

  • Julian López Portero

  • Tania de Alda Catalá

  • Carlos Taxonera

  • Paula Lago

  • Maria J Fernandez-Aceñero

  • Isadora Rosa

  • Ricardo Marcos-Pinto

  • Salomé S Pinho

  • March 15, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Oncology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Cancer Biology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Molecular Biology

  • #4

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Immunology
    • Gastroenterology

  • #5

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Translational Medicine

Original Source(s)

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

  • by Eduarda Leite-Gomes, Mariana C Silva, Ana M Dias, Ângela Fernandes, Guilherme Faria, Rafaela Nogueira, Beatriz Santos-Pereira, Henrique Fernandes-Mendes, Catarina M Azevedo, Joana Raposo, Julian López Portero, Tania de Alda Catalá, Carlos Taxonera, Paula Lago, Maria J Fernandez-Aceñero, Isadora Rosa, Ricardo Marcos-Pinto, Salomé S Pinho

  • March 15, 2025

Related Content

Changes in dietary habits following a colon cancer diagnosis: insights from the prospective ECHO (Eating habits CHanges in Oncologic patients) STUDY 2.0

Cytokine and chemokine networks in colorectal cancer

Multidimensional exploration of the relationship between gut microbiota and colorectal cancer: focus on clinical tumorigenesis and treatment